REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-12-22: Form 6-K; Period of report 2017-12-22; Description FORM 6-K; Document f6k_122217.htm.
- 2017-12-05: Form 6-K; Period of report 2017-12-05; Description FORM 6-K; Document f6k_120517.htm.
- 2017-11-13: Form 6-K; Period of report 2017-11-13; Description FORM 6-K; Document f6k_111317.htm.
- 2017-11-13: Form 6-K; Period of report 2017-11-13; Description FORM 6-K; Document f6k_111317.htm.